Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Triciribine

A tricyclic nucleoside synthesised in 1971, studied as an anticancer agent because it blocks the protein Akt, a cell-growth switch often overactive in tumours; it has not been approved as a medicine. This family brings together the active ingredient and labelled standards.

Did you know?After disappointing results in the 1980s and 1990s it was rediscovered in the early 2000s, when Said Sebti and Jin Cheng showed that it acts on tumours with overactive Akt.

TriciribineGo to the active ingredient →
TriciribineActive ingredientTriciribineCat. No. P-T196-001CAS 35943-35-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.